ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.

NDAQ:PMN - Post by User

ProMIS Neurosciences Inc > 4 Cent David

<< Previous

Bullboard Posts

Next >>

Comment by DavidKingCanadaon Aug 08, 2021 8:40am

85 Views

Post# 33669272

RE:RE:4 Cent David

Is it M101 or ML0L

Just for the record, I am not Buying and Selling every time the SP goes up and down. But was simply stating that with the Volatility there can be ways to make extra Money.

As of now the SP is at 0.24 and the probability it dipping to 0.20 1-2 weeks is very high.

Note: Whenever there is any sort of PR the SP goes up and down and for those not holding long term this is a great way to get in and out!

Is that Youtube Video what you studied in your MBA Program?

Cheers!

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks